Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Legality Of J&J's Remicade Contracting Depends On Share Of Biosimilar Market Foreclosed, Court Rules

Aug 12 2018

• By Brenda Sandburg

Courthouse Pillars & Stairs

Related Content

Pfizer v. J&J Sets Stage For Biosimilar Showdown Over Exclusive Contracts

Sep 21 2017

EpiPen Pricing Got Mylan In Hot Water; Now Sanofi Is Taking Firm To Court

Apr 25 2017

Avoiding ‘Groundhog Day’: US FDA’s Biosimilar Action Plan Applies Lessons From Generic Competition

Jul 23 2018

Biosimilar Litigation Trends: Settlements, Declaratory Judgment Rejections, Congressional Intervention

Aug 12 2018

FDA Commissioner’s Rx For US Biosimilars Market: Reform Contracting Practices And Payment Models

Jul 19 2018

Related Companies

Pfizer Inc.

Johnson & Johnson

Sanofi

Viatris Inc.

Additional Topics

United States Policy Biosimilars Legal Issues BioPharmaceutical

More from Policy & Regulation

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window